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Abstract 
Purpose: The purpose of this study is to identify effective strategies used by Alabama hospitals to manage drug shortages.  
Moreover, this study aims to determine if there are any relationships among hospital size, utilization of a standard policy for drug 
shortage management and perceived usefulness of standard procedures for drug shortages.    
Methods: A paper survey was mailed to 129 hospital pharmacies in Alabama (per the Alabama Hospital Association directory).  The 
survey consisted of 5 demographic questions, questions involving perception of current medication shortages, sources of information 
about shorted drugs, and frequency of discussion at P&T committee meetings. Most importantly, the survey contained questions 
about the use of a standard policy for handling drug shortages, the effectiveness of the policy if one is used, and an open-ended 
question asking the recipient to describe the policy being used.      
Results: A response rate of 55% was achieved as 71 surveys were completed and returned.  Approximately 70% of the survey 
respondents described the current drug shortage issue as a top priority in their pharmacy department.  The pharmacy distributor 
served as the primary source of information regarding drug shortages for 45% of the facilities.  There is a direct relationship between 
size of hospital and likelihood of utilization of a standard policy or procedure for drug shortage management among the sample.  The 
smaller facilities of the sample perceived their management strategies as effective more frequently than the larger hospitals.       
Conclusion: Common components of effective management strategies included extensive communication of shortage details and the 
ability to locate alternative products.  The use of portable technology (e.g., Smart phones and tablets) along with mobile applications 
may emerge as popular means for communicating drug product shortage news and updates within a facility or healthcare system. 
 
 
The manufacturing and supply chain problems of the 
pharmaceutical industry have ballooned in recent years.  In 
2010 alone, the United States Food and Drug Administration 
(FDA) recognized 178 new shortages of products that are 
deemed medically necessary, not including vaccines, 
immunoglobulin products, and other biologics.
1,2
  This figure 
is up from 61 reported shortages in 2005, an approximate 
300% increase.
2
  Many have postulated causes for the lack of 
prescription pharmaceuticals, and the main issue is probably 
a composite of the following:  lack of raw and bulk materials, 
voluntary recalls, manufacturing difficulties, product 
formulation changes, increased regulation of manufacturing 
practices, manufacturers’ production decisions, shifts in 
clinical practice, drug product distribution/ allocation 
restrictions, natural disasters, industry consolidations, 
increased demand, stockpiling by end-users, and non-
traditional distributor usage (gray market).
3
   
 
There have been a few genres of medications that have been 
affected most heavily by the recent problems.  Some of those 
classes include oncology medications, emergency drugs, anti- 
 
 
Corresponding author:  Peter J. Hughes, PharmD, BCPS, 
Samford University Global Drug Information Service, 800 
Lakeshore Drive, Birmingham, AL 35229 
Phone: 205-726-2519; Email: pjhughes@samford.edu 
infective products, anesthetic medications, electrolytes and  
CNS-targeted treatments.
4
 A list of the drugs that are 
currently in short supply or on backorder can be found on the 
FDA’s website.
 5
   
 
The effects of the medication shortages are widespread and 
run deep into the operations of almost every health system in 
the United States.  American health care institutions spend 
countless hours and millions of dollars trying to manage 
inventories of drugs in limited supply.  Additionally, in 2010, 
American health systems spent an estimated $200 million 
due to inflated inventory costs.
6
 Along with increased 
financial burdens, medication shortages cause increased 
labor needs focused on managing inventories and evaluating 
alternative therapy.  One survey claimed that, on average, 
hospitals had to allocate 17-18 full-time employee hours per 
week- mostly pharmacists and technicians- to manage the 
current state and plan for the future state of drug supplies.
8
 
The health systems’ median annual labor cost associated with 
the shortages has been reported to total $216 million.
 8
 
 
Although the labor and financial burdens have placed 
increased stress on health care systems around the country, 
arguably the most significant danger of medication shortages 
is the increased risk of harm to patients.   Shortages have 
been linked to increases in medication errors.
9
  This 
correlation stems from the use of unfamiliar alternative 
treatments or different concentrations or dosage forms of 
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high-risk drugs.  For example, hydromorphone 1mg/mL and 
2mg/mL ampules have been commonly backordered and 
shorted products.
9
 Thus, hospitals must stock higher 
concentrations of 4mg/mL or 10mg/mL to accommodate for 
the indicated pain control.
9
 Subsequently, the risk of a 
potentially fatal overdose has increased due to the use of 
more potent formulations, and there have been reported 
medication errors and near misses.
10
     
 
Medication scarcity is not a new phenomenon, and therefore, 
policy and procedure recommendations for handling such 
problems have been established by entities such as ASHP, 
ISMP, USP and FDA.  The ASHP encourages health care 
professionals to immediately assess the situation once a drug 
shortage is identified.
4
 From an operational standpoint, the 
facility needs to validate the shortage, inventory the stock on 
hand, find potential alternative sources, analyze the purchase 
and use history compared to current usage, estimate how 
long the problem might last and possibly find a supply of 
alternative drug products.
4
 From a therapeutic perspective, 
alternative drug therapies should be identified along with the 
primary patient population that will be affected.
4
  Then, in 
the optimal setting of a meeting with representation from 
multiple health care disciplines, the impact of the medicine’s 
unavailability should be discussed, addressing the changes to 
therapeutic, prescribing, in-house distribution and 
administration processes.
4
  Also, the financial repercussions 
of the changes should be considered.  Once a consensus has 
been reached regarding the proper actions to be taken, mass 
communication and implementation should follow.
4
 Another 
source places high emphasis on communication during a 
shortage and encourages alerts and notices to be visible in 
key areas of the hospital, such as dictation rooms, employee 
parking garages, medical staff lounges and other high traffic 
areas.
11
 Also, drug shortages should be addressed and 
evaluated at every Pharmacy and Therapeutics (P & T) 
committee meeting held by a facility.
11
  
 
There is a lack of state-specific data that identify if the 
previously mentioned standard management strategies are 
being utilized in Alabama to mitigate the problems associated 
with drug shortages.  Also, new and innovative methods 
being used could be identified and made known to other 
facilities.  The purpose of this study is to identify effective 
strategies used by Alabama hospitals to manage drug 
shortages.  Moreover, this study plans to determine if there 
exists any relationship between hospital size, utilization of a 
standard policy for drug shortage management and perceived 
usefulness of the standard procedure. 
  
 
 
Methods 
A 12 question paper survey was mailed out to Alabama 
inpatient pharmacies (n=129), on October 8, 2012 (See 
Appendix A.).  The survey was sent along with a cover letter 
and a self-addressed, stamped envelope for the return of the 
document.   The survey was comprised of questions relating 
to demographics, perceptions of drug shortages, sources of 
information, drug shortage policy, and one open ended 
question to describe the policy.  The Samford University 
Institutional Review Board approved this study.   
 
The demographic questions included the position in the 
pharmacy of the person completing the survey, the size of the 
hospital by number of inpatient beds, the number of full-time 
pharmacists employed by the hospital, and presence of a 
designated purchasing agent as well as clinical pharmacy 
staff.  The next question inquired about the overall 
perception of the drug shortage issue on a scale of “top 
priority” being the most emergent to “not a problem” as least 
emergent.  The following question surveyed the primary 
source used to gain information about drug product 
shortages with options including, the FDA website, ASHP 
website, pharmacy distributor, manufacturers, and an open 
ended option.  The frequency that medication shortages are 
discussed in P&T committee meetings was gauged using a 
scale of always, often, sometimes, seldom or never.  
Questions nine, ten and eleven determined the use of a 
standard procedure for managing drug shortages, and asked 
the participant to characterize and describe the policy if there 
was one in place at the facility.  Finally, a question was posed 
regarding interest in obtaining information about new or 
innovative drug shortage management strategies.       
 
The completion and return of the survey by October 26, 2012 
was incentivized with a chance to win a $100 gift card that 
was randomly selected by an uninvolved third-party.  Each 
survey was labeled prior to distribution with a number, 1 
through 129, in the top left corner of the page.  The number 
on the survey corresponded with the same number on a 
master list of the facilities with addresses.  Upon receipt of 
the completed survey, the envelope was kept unopened until 
the survey could be de-identified by an established third 
party.  The numbers were kept until the deadline, and then 
one number was blindly selected from the container.  The 
chosen number was referenced by the master address list, 
and that entity was awarded the gift card.       
 
Survey variables were nominal and ordinal with one open-
ended response.  All survey item selections were transformed 
into numerical variables to allow for the calculation of 
statistics.  The data was then transferred to an Excel 
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workbook, with the exception of the free text entered for the 
open-ended responses to question eleven.   
 
A frequency table was constructed for the responses of each 
question, and the results were displayed in both raw numbers 
and percentages of total responses.  The size of hospitals was 
also cross-tabulated against the use of a standard policy or 
procedure for managing drug product shortages and against 
the degree of efficacy of the policy. Spearman’s rank 
correlation coefficient was calculated for both relationships 
to determine dependence between the variables.  A 
systematic approach to analyzing the open-ended responses 
was established by identifying the policy descriptions that 
were characterized as effective and looking for common 
phrases or steps.  The same process was performed with the 
responses that were characterized as only “working 
sometimes”.   Finally, a general review of all of the responses 
was performed to identify extremely common phrases 
(occurring in more than 75% of the responses) and extremely 
unique phrases (occurring in less than 5% of the responses).        
 
Results 
Of the 129 mailed surveys, 71 were returned completed, 
lending a response rate of 55%.  An overwhelming majority, 
94.4% (n=67), of the participants were directors of pharmacy, 
or held a comparable position. The distribution of responses 
by hospital size was skewed to the right, but this would be 
expected, as there is a larger quantity of smaller facilities in 
the state versus hospitals with 400 beds or more.  A 50 -99 
bed facility was the most common size that responded with 
22 participants (31.0%).  The complete breakdown can be 
found in Table 1.  Forty-six of the seventy-one facilities 
represented employed between one to five full-time 
pharmacists.  There were 62.0% (n=44) and 60.4% (n=43) of 
the participants that claimed to have a designated drug-
purchasing agent and designated clinical pharmacist or staff, 
respectively.  
 
The overall perception of the drug shortage situation was 
categorized as a “top priority” by 70.0% (n=49) of the 
pharmacy departments, and 17 (24.3%) others viewed the 
issue as “somewhat important”.  About one-half (n=32) of the 
respondents used their distributor as the primary source of 
information about drug product shortages.  The second most 
common source of information was the ASHP website, which 
was listed by 28.6% (n=18) of the participants as their primary 
resource for drug shortage news and updates.  There were 
five responses regarding primary source of information that 
were listed as “other” and then described in free text.  Those 
answers included corporate emails, an iPhone app called Rx 
Shortages, the group purchasing organization (GPO) and a 
third party that monitors the FDA and ASHP information and 
gives daily updates.  Drug Shortages were always discussed in 
P&T committee meetings by 57.8% (n=41) of the hospitals 
and often discussed by 29.6% (n=21) of the hospitals.  Only 
one hospital claimed that drug product shortages were 
seldom topics of discussion at their facility’s P&T committee 
meetings.   
              
There were 41 hospitals (57.7%) that responded as having a 
standard policy or procedure for managing drug shortages. 
The number of facilities with standard policies was also 
analyzed by corresponding facility size.  Figure 1 provides a 
graphic describing those results.  There appeared to be a 
correlation between size of the hospital and use of a standard 
procedure.  Only 31% (5 of 16) of smaller hospitals (< 50 
beds) utilized a drug shortage management policy, whereas, 
63% (5 of 8) and 67% (4 of 6) of larger hospitals (250-399 
beds and >300 beds, respectively) had standard procedures 
implemented.  Spearman’s rho (ρ), which is a rank correlation 
coefficient, for this comparison was 0.7, where hospitals were 
ranked in size from largest to smallest and percentages of 
perceived effective policies were also ranked from largest to 
smallest.     
 
The responses to question 10 are displayed in Figure 2 based 
on percentages of total responses categorized by facility size.  
The highest percentages of respondents who classified their 
standard procedure for drug shortage management as 
effective were associated with facilities with <50 beds (40%) 
and 100-249 beds (38%).  Neither of the two largest hospital 
size categories had any respondent to classify their policy as 
effective.  The data for this comparison was ranked in order 
largest hospital size to smallest and largest percentage of 
effective policies to smallest.  Spearman’s rho (ρ) for this 
comparison was -0.825. 
 
Analysis of the open-ended responses associated with the 
policies that were perceived as effective by respondents 
revealed a few common characteristics.  First, communication 
with physicians through various means (memos, emails, 
phone calls, faxes, P&T meetings, etc) was a staple among the 
responses.  Also, locating alternative supplies or finding a 
therapeutic alternative was listed in multiple responses. 
Finally, prioritizing the use of remaining stock of the shorted 
drug was mentioned as part of a few of the standard 
procedures. 
 
The policies that were deemed to only be successful 
sometimes were also analyzed and found to have no unique 
descriptors to differentiate their policy from the others that 
were described.  An evaluation of all the responses resulted 
in discovering three characteristics that were frequently 
listed as a part of the drug shortage management strategies.  
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Once again, communication of the status of the shortage and 
therapeutic plan resonated throughout the responses. The 
vehicle for communication varied among the answers, but it 
appears that notification to prescribers and other members 
of the healthcare team is paramount when dealing with 
medication shortages.  The ability to systematically select a 
therapeutic alternative and find a supply source was the 
second most common feature among all the responses.  
Finally, working in a committee setting, such as a P&T or 
Medical Staff committee, was used in 26 out of 41 policies to 
develop and implement the specific plan for each specific 
shortage.  A few of the unique elements that were recognized 
include placing notices on the machines, the clinical 
pharmacist vs. pharmacists working directly with the 
pharmacy buyer to control and locate inventory, and using 
automatic formulary substitution protocols. 
 
In response to the last question on the survey, approximately 
93% (n=63) of the participants indicated interest in gaining 
information on new and innovative strategies for managing 
drug shortages. 
 
Discussion 
As a novel project relating to the subject matter of drug 
shortages in Alabama hospital pharmacies, a lot was learned 
about the sample.  It was no surprise that the vast majority of 
participants served as the director of pharmacy because the 
letter was addressed to director.  The top priority rating given 
by 70% of the respondents is a solid indicator that the issue 
of drug shortages is still a relevant topic for investigation.  
Survey results published by ASHP in October 2011 claimed 
that the ASHP website was the most widely utilized source of 
information about drug product shortages followed by the 
wholesaler website, then the group purchasing website and 
FDA website.  The Alabama hospital pharmacy directors who 
completed this survey portrayed the use of the distributor 
(wholesaler) as the primary source of information for news 
and updates.  Inpatient pharmacies are in frequent contact 
with their distributor every week; thus, this relationship 
seems to serve as the most pragmatic source of information.  
One extremely interesting response to this survey explained 
that one facility uses a mobile application, called Rx 
Shortages, as its main source of information on shorted 
medications.  This application pulls information from both the 
ASHP website and FDA website, and it compiles it into a 
database.  With the rise in use of smart phones and tablets in 
the medical and pharmacy fields, a mobile application could 
serve as an effective means of internal communication 
regarding drug shortages for an institution or health system.   
 
The function of standing committees in healthcare 
institutions, such as P&T and Medical Staff committees is 
multifaceted.  Moreover, it is important that operational 
issues, such as medication shortages, are discussed at these 
multi-disciplinary meetings.  As portrayed through the results 
of this study, 41 of the 71 respondents always discuss 
medication shortages at their P&T meetings and also 
understand that the committees are appropriate for deciding 
the course of action and initiating the communication 
pathways.  This is also consistent with the recommendation 
made by ASHP, the FDA, and ISMP. 
          
Another characteristic of the Alabama inpatient institutions 
that responded was the strong positive relationship between 
facility size and the presence of a standard management 
policy.  The correlation was supported by a Spearman’s 
coefficient calculation.  This observation could occur in part 
to the higher level of structure and organization that comes 
along with larger operations.   With small facilities, the 
personnel may fill multiple roles which simplify decision-
making processes and lines of communication; therefore, a 
standard policy may not always be necessary because one or 
two clinicians may handle every portion of the management 
process. 
 
Even though a higher percentage of larger hospitals followed 
a set policy, the percentage of smaller facilities with 
established guidelines that classified their operations as 
effective was higher.  This inverse correlation was supported 
with a strongly negative Spearman’s coefficient.   Smaller 
facilities may be more apt to effectively manage drug 
shortages due to having smaller inventories to control and 
having a more intimate work environment among 
pharmacists, physicians and other healthcare professionals.    
 
Although it was not possible to identify any new strategies 
that could be directly applied to increased success in 
managing drug shortages, there were common themes 
throughout the open-ended policy description responses.  
Common components of effective management strategies 
included the ability to extensively communicate the details of 
the shortage and the ability to locate therapeutic 
alternatives..  Both of these strategies are key pieces of the 
standard guidelines that were published by the ASHP, FDA 
and ISMP.    
 
The limitations associated with this study include the lack of 
objective criteria to define efficacy in the survey.  Also, there 
is a possibility of measurement bias when evaluating the 
open-ended responses.  
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Conclusion  
Due to the severity of drug product shortages over the past 
few years and the publicity that has been gained, the federal 
government and the FDA have made strides to alleviate the 
burden on healthcare institutions.
13,14
 This is accomplished by 
requiring manufacturers to identify drugs that could be prone 
to shortages and report any fluctuation in production or 
inventory.  However, it is not enough for hospitals to rely on 
external means for managing shortages.  Proper procedures 
and methods need to be used internally to control the risks 
and costs associated with drug shortages.  However, not 
every healthcare facility or system operates exactly the same.  
Some hospitals have adapted recommended guidelines for 
drug shortage management to fit their healthcare model.  It is 
important to continually reassess the efficacy and practicality 
of these strategies.   
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Table 1. 
 
 
Demographic Results 
Demographic  No. (%) of Respondents 
Position in Pharmacy   
Director of Pharmacy 67 (94.4%) 
Assistant Director/Clinical 
Director 
3 (4.2%) 
Staff Pharmacist --- 
Clinical Pharmacist 1 (1.4%) 
Buyer/ Purchasing Agent --- 
Technician --- 
No. of Beds in Facility   
<50  16 (22.5%) 
50-99 22 (31.0%) 
100-249 18 (25.4%) 
0-399 9 (12.7%) 
>399 6 (8.4%) 
No. of Full-time Pharmacists   
1-5 46 (64.8%) 
6-10 8 (11.3%) 
11-20 7 (9.8%) 
>20 10 (14.1%) 
Designated Purchasing Agent Employed  
Yes 44 (62.0%) 
No 27 (38.0%) 
Designated Clinical Pharmacist(s) Employed  
Yes 43 (60.6%) 
No 28 (39.4%) 
Original Research PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                             2013, Vol. 4, No. 2, Article 115                  INNOVATIONS in pharmacy   7 
 
 
 
Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 
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Appendix A. 
Drug Shortage Management in Alabama Hospital Pharmacies 
 
Please circle ONE response unless instructed otherwise 
1. Which answer best describes your role/position in the pharmacy? 
a. Director of Pharmacy 
b. Assistant Director/ Clinical Pharmacy Director 
c. Staff Pharmacist 
d. Clinical Pharmacist 
e. Buyer/ Purchasing agent 
f. Technician 
 
2. Please, choose a bed range that describes your facility: 
a. <50 beds 
b. 50-99 beds 
c. 100-249 beds 
d. 250-399 beds 
e. ≥400 beds 
 
3. How many full time pharmacists are employed at your facility? (including central and clinical staff) 
a. 1-5 
b. 6-10 
c. 11-20 
d. >20 
 
4. Does your facility have a designated purchasing agent? 
a. Yes 
b. No 
 
5. Does your facility have a clinical pharmacy staff? 
a. Yes 
b. No 
 
6. What is your pharmacy department’s perception of the recent drug shortage issue? 
a. Top priority 
b. Somewhat important 
c. Just a part of operations 
d. Not a problem 
 
7. What source is primarily used for gaining information regarding the shortage of a drug? 
a. FDA website 
b. ASHP website 
c. Distributor 
d. Manufacturer 
e. Other______________________ 
 
8. How often are drug shortages discussed in the P&T committee meetings at your facility? 
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a. Always 
b. Often 
c. Sometimes 
d. Seldom 
e. Never 
 
9. Does your facility have a standard policy or procedure when a drug shortage has been identified? 
a. Yes 
b. No 
 
10. If you answered yes to question 9, how would you characterize the current policies and procedures for dealing with drug 
shortages? 
a. Effective 
b. Satisfactory 
c. Flawed 
d. Useless 
 
11. If you answered yes to question 9, would you please explain your current policy for managing drug shortages (Do you/how 
do you communicate shortages, Do you/how do you select alternative medications and prioritize use of drugs in short 
supply)? 
 
12. Would you be interested in obtaining information regarding other new or innovative strategies for the management of drug 
shortages based upon the feedback of other Alabama hospital pharmacies? 
a. Yes 
b. No 
 
 
 
